ConductScience.org, home

Paper995158

Effect of insulin and glucagon on fulminant murine hepatitis.

Farivar M and 3 others. N Engl J Med, 1976. Cited by 94 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effect of insulin and glucagon on fulminant murine hepatitis. Papers, record 995158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/995158

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of insulin and glucagon on fulminant murine hepatitis.
PubMed
Journal
N Engl J Med
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
3.98
iCite
Revised in PubMed
2011-11-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farivar MM
2Wands JRJ R
3Isselbacher KJK J
4Bucher NLN L

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucagonMajor topic
Hepatitis AMajor topic
InsulinMajor topic
Liver RegenerationMajor topic
Acute Disease
Animals
Disease Models, Animal
Drug Synergism
Female
Mice
Time Factors

Source PubMed

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
34,966,588Preclinical models of acute liver failure: a comprehensive review.PeerJ2021https://conductscience.org/library/papers/34966588PubMed
31,191,707Metabolic and Epigenetic Action Mechanisms of Antidiabetic Medicinal Plants.Evid Based Complement Alternat Med2019https://conductscience.org/library/papers/31191707PubMed
16,382,351Acute liver failure: a critical appraisal of available animal models.Metab Brain Dis2005https://conductscience.org/library/papers/16382351PubMed
9,213,259Prolonged intrahepatic cholestasis in acute-onset, severe autoimmune hepatitis.J Gastroenterol1997https://conductscience.org/library/papers/9213259PubMed
8,444,417Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure.Hepatology1993https://conductscience.org/library/papers/8444417PubMed
8,391,447Glycogen storage disease I and hepatocellular tumours.Eur J Pediatr1993https://conductscience.org/library/papers/8391447PubMed
7,429,306Evidence for liver cell proliferation during fatal acute liver failure.Gut1980https://conductscience.org/library/papers/7429306PubMed
6,433,587Acute hepatic failure in children.Yale J Biol Med1984https://conductscience.org/library/papers/6433587PubMed
6,402,285Carbon tetrachloride poisoning treated with hemodialysis and total parenteral nutrition.Can Med Assoc J1983https://conductscience.org/library/papers/6402285PubMed
3,539,743
The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine.
Hepatology1986https://conductscience.org/library/papers/3539743PubMed
3,315,819Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis.Gastroenterol Jpn1987https://conductscience.org/library/papers/3315819PubMed
2,715,130Stimulating effects of bovine small intestine mucosal factors on rat hepatocyte development.In Vitro Cell Dev Biol1989https://conductscience.org/library/papers/2715130PubMed
2,663,609A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis.Gastroenterol Jpn1989https://conductscience.org/library/papers/2663609PubMed
2,472,994
Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial.
Gastroenterol Jpn1989https://conductscience.org/library/papers/2472994PubMed
2,298,913Effect of ethanol on polyamine synthesis during liver regeneration in rats.J Clin Invest1990https://conductscience.org/library/papers/2298913PubMed
2,032,521Insulin and glucagon therapy of acute hepatic failure.Dig Dis Sci1991https://conductscience.org/library/papers/2032521PubMed
2,032,519Animal models of fulminant hepatic failure.Dig Dis Sci1991https://conductscience.org/library/papers/2032519PubMed
1,836,544In vivo modification of hepatopathy in rat by intestine epithelial HGF.Naturwissenschaften1991https://conductscience.org/library/papers/1836544PubMed
1,709,604Insulin and glucagon levels in fulminant hepatic failure in man.Dig Dis Sci1991https://conductscience.org/library/papers/1709604PubMed
1,702,048Treatment of fulminant hepatic failure with insulin and glucagon. A randomized, controlled trial.Dig Dis Sci1991https://conductscience.org/library/papers/1702048PubMed

See all 27 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/995158

GET https://conductscience.org/api/papers/v1/995158/cited_by?page=2